Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
Conclusions
This study supports the potential use of serum ferritin values for predicting the long-term prognosis of patients with MASLD.
Source: Gut - Category: Gastroenterology Authors: Armandi, A., Sanavia, T., Younes, R., Caviglia, G. P., Rosso, C., Govaere, O., Liguori, A., Francione, P., Gallego-Duran, R., Ampuero, J., Pennisi, G., Aller, R., Tiniakos, D., Burt, A., David, E., Vecchio, F., Maggioni, M., Cabibi, D., McLeod, D., Pareja Tags: Gut Hepatology Source Type: research
More News: Alcoholism | Cancer | Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Fatty Liver Disease (FLD) | Gastroenterology | Heart | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Statistics | Study | Urology & Nephrology